Older Age of Onset Predicts Response to Vagal Nerve Stimulator Implantation in Patients With Medically Refractory Epilepsy

INTRODUCTION Vagus nerve stimulation (VNS) results in a clinically meaningful response in a subset of patients with medically refractory epilepsy. Predictors of positive treatment response remain poorly defined. METHODS We present a retrospective analysis of patients with medically refractory epilep...

Full description

Saved in:
Bibliographic Details
Published inNeurosurgery Vol. 67; no. Supplement_1
Main Authors Riestenberg, Robert, Sherman, Alain E, Clark, Austin J.S, Zwienenberg, Marike, Shahlaie, Kiarash, Alden, Tord D, Bandt, S. Kathleen
Format Journal Article
LanguageEnglish
Published Philadelphia Wolters Kluwer Health, Inc 01.12.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:INTRODUCTION Vagus nerve stimulation (VNS) results in a clinically meaningful response in a subset of patients with medically refractory epilepsy. Predictors of positive treatment response remain poorly defined. METHODS We present a retrospective analysis of patients with medically refractory epilepsy who underwent VNS implantation at two institutions. Age of epilepsy onset, epilepsy risk factors (e.g., family history, traumatic brain injury, encephalitis), EEG and MRI reports, pre-VNS seizure frequency, and seizure frequency at last follow-up were extracted from the electronic record. Patients were categorized as seizure-free (cutoff ≥6 months), ≥50% seizure frequency reduction, or clinically insignificant effect. Time elapsed from VNS implantation to treatment effect was recorded. Univariate predictors of ≥50% seizure frequency reduction and seizure freedom were determined using Cox proportional hazards analysis. Univariate predictors with p < 0.05 were included in multivariate Cox regression models. RESULTS Eighty-seven patients were included in the study. Fifty-three (60.9%) patients achieved ≥50% seizure frequency reduction and 17 (19.5%) patients became seizure-free. Right-sided seizure onset (left vs. right HR = 0.376, P = .021; bilateral vs. right HR = 0.497, P = .047), history of stroke (HR = 2.679, P = .039), and age of epilepsy onset ≥15 years (HR = 2.122, P = .008) were significant univariate predictors of ≥50% seizure frequency reduction. Left hand dominance (HR = 3.811, P = .025), age of epilepsy onset ≥15 years (HR = 3.145, P = .029), and pre-VNS seizure frequency <5 per month (HR = 3.887, P = .011) were significant univariate predictors of seizure freedom. Age of epilepsy onset ≥15 years was the only significant multivariate predictor of ≥50% seizure frequency reduction (HR = 1.962, P = .02). Left hand dominance (HR = 5.637, P = .006) and pre-VNS seizure frequency <5 per month (HR = 3.789, P = .021) were predictive of seizure freedom in multivariate analysis. CONCLUSION Age of epilepsy onset of 15 years or later predicts significant reduction in seizure frequency following VNS, and left-hand dominance and pre-VNS seizure frequency <5 per month predict seizure freedom. These findings may be used to identify ideal candidates for VNS.
ISSN:0148-396X
1524-4040
DOI:10.1093/neuros/nyaa447_632